BETNOVATE C

This brand name is authorized in New Zealand, Poland, Turkey.

Active ingredients

The drug BETNOVATE C contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Betamethasone UNII `9IFA5XM7R2` - BETAMETHASONE VALERATE
	Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties.
	Read more about Betamethasone
`2`	Clioquinol UNII `7BHQ856EJ5` - CLIOQUINOL
	Read more about Clioquinol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D07BC01	Betamethasone and antiseptics	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07B Corticosteroids, combinations with antiseptics → D07BC Corticosteroids, potent, combinations with antiseptics
Discover more medicines within D07BC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NZ	Medicines and Medical Devices Safety Authority	175
PL	Rejestru Produktów Leczniczych	100087363, 100228295
TR	İlaç ve Tıbbi Cihaz Kurumu	8699522350445, 8699522356331, 8699522359318, 8699522380459, 8699522386345, 8699522389322

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.